Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.

Liver international : official journal of the International Association for the Study of the Liver - 1 Nov 2010

Manolakopoulos Spilios, Deutsch Melanie J, Anagnostou Olga, Karatapanis Stelios, Tiniakou Elli, Papatheodoridis George V, Georgiou Ekaterini, Manesis Emmanuel, Tzourmakliotis Dimitris, Archimandritis Athanasios J

Abstract excerpt

INTRODUCTION AND AIMS: International guidelines and routine clinical practice express concerns about antiviral treatment in intravenous drug users (IDUs). We analysed the effect of IDU and/or substitution therapy on chronic hepatitis C (CHC) treatment adherence and response. PATIENTS AND METHODS: Intravenous drug users with CHC were divided into three groups: (A) patients on a substitution programme; (B) active...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraindications
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Users

Share to Greece

Share to Interferons

Share to Medication Adherence

Share to Ribavirin

Share to Substance Abuse, Intravenous

Source

Identifiers

PMID: 20846344
DOI: 10.1111/j.1478-3231.2010.02341.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.PMID 20846344Read ↗

Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.Semantic proximity Read ↗

Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes.Semantic proximity Read ↗

Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysis.Semantic proximity Read ↗

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.Semantic proximity Read ↗

Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.Semantic proximity Read ↗

Management of hepatitis C virus (HCV) infection in drug substitution programs.Semantic proximity Read ↗

Should active injecting drug users receive treatment for chronic hepatitis C?Semantic proximity Read ↗

The success of treatment of chronic hepatitis C in opiate addicts in Clinical Center of Vojvodina.Semantic proximity Read ↗

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.Semantic proximity Read ↗

Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.Semantic proximity Read ↗

[Treatment of hepatitis C in intravenous drug users].Semantic proximity Read ↗

[The treatment of hepatitis C].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.